These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2952500)

  • 41. Clarithromycin in vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin.
    Hoover WW; Barrett MS; Jones RN
    Diagn Microbiol Infect Dis; 1992; 15(3):259-66. PubMed ID: 1533827
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rokitamycin: bacterial resistance to a 16-membered ring macrolide differs from that to 14- and 15-membered ring macrolides.
    Braga PC
    J Chemother; 2002 Apr; 14(2):115-31. PubMed ID: 12017366
    [TBL] [Abstract][Full Text] [Related]  

  • 43. In vitro study with ciprofloxacin: interpretive criteria of agar diffusion test according to standards of the NCCLS and DIN.
    Grimm H
    Am J Med; 1987 Apr; 82(4A):376-80. PubMed ID: 3578326
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interpretive criteria for CI-960 (AM-1091, PD127391) disk diffusion tests using 5-microgram disks.
    Jones RN; Erwin ME; Barrett MS
    Diagn Microbiol Infect Dis; 1992; 15(4):379-81. PubMed ID: 1319303
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Susceptibility of twenty penicillin-susceptible and -resistant pneumococci to levofloxacin, ciprofloxacin, ofloxacin, erythromycin, azithromycin, and clarithromycin by MIC and time-kill.
    Visalli MA; Jacobs MR; Appelbaum PC
    Diagn Microbiol Infect Dis; 1997 Jul; 28(3):131-7. PubMed ID: 9294703
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Comparison of 30 microgram and 120 microgram gentamicin disks for the prediction of gentamicin resistance in Enterococcus faecalis.
    Kronvall G; Ringertz S; Nyström S; Rylander M; Theodorsson E
    APMIS; 1991 Oct; 99(10):887-92. PubMed ID: 1930962
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [In vitro activity of roxithromycin, new semisynthetic macrolide against obligate anaerobes].
    Dubreuil L; Devos J; Romond C; Bryskier A
    Pathol Biol (Paris); 1986 May; 34(5):440-4. PubMed ID: 3534717
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of disk susceptibility testing of fosfomycin tromethamine.
    Pfaller MA; Barry AL; Fuchs PC
    Diagn Microbiol Infect Dis; 1993 Jul; 17(1):67-70. PubMed ID: 8359009
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimicrobial activity of coumermycin and recommendations for disk diffusion tests with 5- and 15-micrograms disks.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1987 May; 7(1):77-82. PubMed ID: 3691036
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The in vitro activity of some 14-, 15- and 16- membered macrolides against Staphylococcus spp., Legionella spp., Mycoplasma spp. and Ureaplasma urealyticum.
    Felmingham D; Robbins MJ; Sanghrajka M; Leakey A; Ridgway GL
    Drugs Exp Clin Res; 1991; 17(2):91-9. PubMed ID: 1650694
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of the KOH test and the antibiotic disk test in routine clinical anaerobic bacteriology.
    Bourgault AM; Lamothe F
    J Clin Microbiol; 1988 Oct; 26(10):2144-6. PubMed ID: 3183000
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Interpretive criteria of antimicrobial disk susceptibility tests with cefpodoxime.
    Grimm H
    Infection; 1991; 19(5):380-2. PubMed ID: 1800381
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Haemophilus test medium interpretive criteria for disk diffusion susceptibility tests with cefdinir, cefetamet, cefmetazole, cefpodoxime, cefdaloxime (RU29246, HR-916 metabolite), and trospectomycin.
    Jones RN; Erwin ME
    Diagn Microbiol Infect Dis; 1992; 15(8):693-701. PubMed ID: 1478050
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Clinical laboratory approach to estimating the effective administration dose of imipenem/cilastatin. Evaluation of the disk susceptibility test and its interpretation system].
    Matsuo K; Uete T
    Jpn J Antibiot; 1989 Nov; 42(11):2377-92. PubMed ID: 2621780
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Susceptibility testing of anaerobic bacteria with 100-microg carbenicillin disks.
    Laslie WW; Lambe DW
    Antimicrob Agents Chemother; 1976 Jul; 10(1):112-8. PubMed ID: 984743
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Proposed zone standards for interpretation of fortimicin A disk diffusion tests.
    Barry AL; Thornsberry C; Jones RN
    J Clin Microbiol; 1983 Aug; 18(2):440-2. PubMed ID: 6619294
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modified broth-disk method for testing the antibiotic susceptibility of anaerobic bacteria.
    Wilkins TD; Thiel T
    Antimicrob Agents Chemother; 1973 Mar; 3(3):350-6. PubMed ID: 4790595
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Antibacterial activities of erythromycins A, B, C, and D and some of their derivatives.
    Kibwage IO; Hoogmartens J; Roets E; Vanderhaeghe H; Verbist L; Dubost M; Pascal C; Petitjean P; Levol G
    Antimicrob Agents Chemother; 1985 Nov; 28(5):630-3. PubMed ID: 4091529
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Simple disk technique for detection of nitrate reduction by anaerobic bacteria.
    Wideman PA; Citronbaum DM; Sutter VL
    J Clin Microbiol; 1977 Mar; 5(3):315-9. PubMed ID: 323277
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vaspar broth-disk procedure for antibiotic susceptibility testing of anaerobic bacteria.
    West SE; Wilkins TD
    Antimicrob Agents Chemother; 1980 Feb; 17(2):288-91. PubMed ID: 7387149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.